ID   GFI1_RAT                Reviewed;         423 AA.
AC   Q07120;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 1.
DT   29-MAY-2024, entry version 170.
DE   RecName: Full=Zinc finger protein Gfi-1;
DE   AltName: Full=Growth factor independent protein 1;
GN   Name=Gfi1; Synonyms=Gfi-1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], DEVELOPMENTAL STAGE, AND TISSUE SPECIFICITY.
RX   PubMed=8441411; DOI=10.1128/mcb.13.3.1759-1768.1993;
RA   Gilks C.B., Bear S.E., Grimes H.L., Tsichlis P.N.;
RT   "Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to
RT   IL-2-independent growth following activation of a gene (Gfi-1) encoding a
RT   novel zinc finger protein.";
RL   Mol. Cell. Biol. 13:1759-1768(1993).
RN   [2]
RP   INTERACTION WITH ZBTB17, AND FUNCTION.
RX   PubMed=20190815; DOI=10.1038/onc.2010.48;
RA   Liu Q., Basu S., Qiu Y., Tang F., Dong F.;
RT   "A role of Miz-1 in Gfi-1-mediated transcriptional repression of CDKN1A.";
RL   Oncogene 29:2843-2852(2010).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20 AND SER-57, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4]
RP   STRUCTURE BY NMR OF 312-393 IN COMPLEX WITH DNA.
RX   PubMed=20153336; DOI=10.1016/j.jmb.2010.02.006;
RA   Lee S., Doddapaneni K., Hogue A., McGhee L., Meyers S., Wu Z.;
RT   "Solution structure of Gfi-1 zinc domain bound to consensus DNA.";
RL   J. Mol. Biol. 397:1055-1066(2010).
CC   -!- FUNCTION: Transcription repressor essential for hematopoiesis (By
CC       similarity). Functions in a cell-context and development-specific
CC       manner (By similarity). Binds to 5'-TAAATCAC[AT]GCA-3' in the promoter
CC       region of a large number of genes (By similarity). Component of several
CC       complexes, including the EHMT2-GFI1-HDAC1, AJUBA-GFI1-HDAC1 and RCOR-
CC       GFI-KDM1A-HDAC complexes, that suppress, via histone deacetylase (HDAC)
CC       recruitment, a number of genes implicated in multilineage blood cell
CC       development (By similarity). Regulates neutrophil differentiation,
CC       promotes proliferation of lymphoid cells, and is required for
CC       granulocyte development (By similarity). Inhibits SPI1 transcriptional
CC       activity at macrophage-specific genes, repressing macrophage
CC       differentiation of myeloid progenitor cells and promoting granulocyte
CC       commitment (By similarity). Mediates, together with U2AF1L4, the
CC       alternative splicing of CD45 and controls T-cell receptor signaling (By
CC       similarity). Regulates the endotoxin-mediated Toll-like receptor (TLR)
CC       inflammatory response by antagonizing RELA (By similarity). Cooperates
CC       with CBFA2T2 to regulate ITGB1-dependent neurite growth (By
CC       similarity). Controls cell-cycle progression by repressing CDKNIA/p21
CC       transcription in response to TGFB1 via recruitment of GFI1 by ZBTB17 to
CC       the CDKNIA/p21 and CDKNIB promoters (PubMed:20190815). Required for the
CC       maintenance of inner ear hair cells (By similarity). In addition to its
CC       role in transcription, acts as a substrate adapter for PRMT1 in the DNA
CC       damage response: facilitates the recognition of TP53BP1 and MRE11
CC       substrates by PRMT1, promoting their methylation and the DNA damage
CC       response (By similarity). {ECO:0000250|UniProtKB:P70338,
CC       ECO:0000250|UniProtKB:Q99684, ECO:0000269|PubMed:20190815}.
CC   -!- SUBUNIT: Interacts with U2AF1L4. Component of RCOR-GFI-KDM1A-HDAC
CC       complexes. Interacts directly with RCOR1, KDM1A and HDAC2. Also
CC       interacts with HDAC1. regions. Interacts (via the zinc-finger domain)
CC       with ARIH2; the interaction prevents GFI1 ubiquitination and
CC       proteasomal degradation. Interacts with PIAS3; the interaction relieves
CC       the inhibitory effect of PIAS3 on STAT3-mediated transcriptional
CC       activity. Forms a complex with EHMT2 and HDAC1 to promote 'Lys-9'
CC       dimethylation of H3 (H3K9Me2) and repress expression of target genes.
CC       Interacts directly with EHMT2. Component of the GFI1-AJUBA-HDAC1
CC       repressor complex. Interacts directly with AJUBA (via ITS LIM domains);
CC       the interaction results in the HDAC-dependent corepression of a subset
CC       of GFI1 target genes and, occurs independent of the SNAG domain.
CC       Interacts with SPI1; the interaction inhibits SPI1 transcriptional
CC       activity targeted at macrophage-specific genes, repressing macrophage
CC       differentiation of myeloid progenitor cells and promoting granulocyte
CC       commitment (By similarity). Interacts with RUNX1T1; the interaction
CC       represses HDAC-mediated transcriptional activity. Interacts with RELA;
CC       the interaction occurs on liposaccharide (LPS) stimulation controls
CC       RELA DNA binding activity and regulates endotoxin-mediated TOLL-like
CC       receptor inflammatory response (By similarity). Interacts (via the C-
CC       terminal zinc fingers) with ZBTB17; the interaction results in the
CC       recruitment of GFI1 to the CDKN1A/p21 promoter and repression of
CC       CDKN1A/p21 transcription. {ECO:0000250, ECO:0000250|UniProtKB:P70338,
CC       ECO:0000269|PubMed:20153336, ECO:0000269|PubMed:20190815}.
CC   -!- INTERACTION:
CC       Q07120; Q96KQ7: EHMT2; Xeno; NbExp=3; IntAct=EBI-4289236, EBI-744366;
CC       Q07120; Q13105-1: ZBTB17; Xeno; NbExp=2; IntAct=EBI-4289236, EBI-15753185;
CC       Q07120; Q60821: Zbtb17; Xeno; NbExp=3; IntAct=EBI-4289236, EBI-11598394;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Colocalizes with
CC       PIAS3 and RUNX1T1 in nuclear dots. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Restricted to lymphoid tissues and testes in adult
CC       animals. {ECO:0000269|PubMed:8441411}.
CC   -!- DEVELOPMENTAL STAGE: Expression enhanced late after interaction of IL-2
CC       with its receptor, approximately when cells enter S phase.
CC       {ECO:0000269|PubMed:8441411}.
CC   -!- DOMAIN: Zinc fingers 3,4 and 5 are required for DNA binding and for
CC       interaction with SPI1.
CC   -!- DOMAIN: The SNAG domain of GFIs is required for nuclear location and
CC       for interaction with some corepressors. {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L06986; AAA41212.1; -; mRNA.
DR   PIR; A48152; A48152.
DR   RefSeq; NP_036698.1; NM_012566.1.
DR   RefSeq; XP_008768139.1; XM_008769917.2.
DR   RefSeq; XP_008768140.1; XM_008769918.2.
DR   RefSeq; XP_017454563.1; XM_017599074.1.
DR   PDB; 2KMK; NMR; -; A=312-393.
DR   PDBsum; 2KMK; -.
DR   AlphaFoldDB; Q07120; -.
DR   SMR; Q07120; -.
DR   DIP; DIP-48689N; -.
DR   IntAct; Q07120; 5.
DR   STRING; 10116.ENSRNOP00000002807; -.
DR   iPTMnet; Q07120; -.
DR   PhosphoSitePlus; Q07120; -.
DR   PaxDb; 10116-ENSRNOP00000002807; -.
DR   Ensembl; ENSRNOT00000002807.4; ENSRNOP00000002807.2; ENSRNOG00000002042.6.
DR   Ensembl; ENSRNOT00055041363; ENSRNOP00055033663; ENSRNOG00055024076.
DR   Ensembl; ENSRNOT00060019630; ENSRNOP00060015446; ENSRNOG00060011588.
DR   Ensembl; ENSRNOT00065020805; ENSRNOP00065016011; ENSRNOG00065012750.
DR   GeneID; 24388; -.
DR   KEGG; rno:24388; -.
DR   UCSC; RGD:2680; rat.
DR   AGR; RGD:2680; -.
DR   CTD; 2672; -.
DR   RGD; 2680; Gfi1.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000156166; -.
DR   HOGENOM; CLU_002678_94_9_1; -.
DR   InParanoid; Q07120; -.
DR   OrthoDB; 5341097at2759; -.
DR   PhylomeDB; Q07120; -.
DR   TreeFam; TF350784; -.
DR   EvolutionaryTrace; Q07120; -.
DR   PRO; PR:Q07120; -.
DR   Proteomes; UP000002494; Chromosome 14.
DR   Bgee; ENSRNOG00000002042; Expressed in thymus and 8 other cell types or tissues.
DR   GO; GO:0016604; C:nuclear body; ISO:RGD.
DR   GO; GO:0016363; C:nuclear matrix; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0017053; C:transcription repressor complex; ISS:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0001217; F:DNA-binding transcription repressor activity; ISO:RGD.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0140767; F:enzyme-substrate adaptor activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0045165; P:cell fate commitment; ISO:RGD.
DR   GO; GO:0001708; P:cell fate specification; ISO:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0006974; P:DNA damage response; ISS:UniProtKB.
DR   GO; GO:0042491; P:inner ear auditory receptor cell differentiation; ISO:RGD.
DR   GO; GO:0042472; P:inner ear morphogenesis; ISO:RGD.
DR   GO; GO:0007638; P:mechanosensory behavior; ISO:RGD.
DR   GO; GO:0009996; P:negative regulation of cell fate specification; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0042660; P:positive regulation of cell fate specification; ISO:RGD.
DR   GO; GO:0070105; P:positive regulation of interleukin-6-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0034121; P:regulation of toll-like receptor signaling pathway; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 6.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR23226; ZINC FINGER AND SCAN DOMAIN-CONTAINING; 1.
DR   PANTHER; PTHR23226:SF405; ZINC FINGER PROTEIN 135-LIKE; 1.
DR   Pfam; PF00096; zf-C2H2; 6.
DR   SMART; SM00355; ZnF_C2H2; 6.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 3.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 6.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 6.
PE   1: Evidence at protein level;
KW   3D-structure; DNA-binding; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..423
FT                   /note="Zinc finger protein Gfi-1"
FT                   /id="PRO_0000047195"
FT   ZN_FING         256..279
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         285..307
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         313..335
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         341..363
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         369..391
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         397..420
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          1..102
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1..20
FT                   /note="SNAG domain"
FT                   /evidence="ECO:0000250"
FT   REGION          141..258
FT                   /note="Required for interaction with RELA"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        63..81
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         20
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         57
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   STRAND          316..318
FT                   /evidence="ECO:0007829|PDB:2KMK"
FT   STRAND          321..324
FT                   /evidence="ECO:0007829|PDB:2KMK"
FT   HELIX           325..336
FT                   /evidence="ECO:0007829|PDB:2KMK"
FT   STRAND          344..346
FT                   /evidence="ECO:0007829|PDB:2KMK"
FT   STRAND          349..352
FT                   /evidence="ECO:0007829|PDB:2KMK"
FT   HELIX           353..364
FT                   /evidence="ECO:0007829|PDB:2KMK"
FT   TURN            372..374
FT                   /evidence="ECO:0007829|PDB:2KMK"
FT   STRAND          377..380
FT                   /evidence="ECO:0007829|PDB:2KMK"
FT   HELIX           381..391
FT                   /evidence="ECO:0007829|PDB:2KMK"
SQ   SEQUENCE   423 AA;  45858 MW;  FC39B6100D684D14 CRC64;
     MPRSFLVKSK KAHSYHQPRS PGPDYSLRLE TVPVPGRADG GAVSAGESKM EPRERLSPES
     QLTEAPDRAS ASPNSCEGSV CDPSSEFEDY WRPPSPSVSP ASEKSLCRSL DEAQPYTLPF
     KPYAWSGLAG SDLRHLVQSY RQCSALERSA GLSLFCERGA ESGRPAARYG SEQAAGGAGA
     GQPGSCGAAS GATSAGGLGL YGDFAPAAAG LFERPSTAAG RLYQDRGHEL HADKSVGVKV
     ESELLCTRLL LGGGSYKCIK CSKVFSTPHG LEVHVRRSHS GTRPFACEMC GKTFGHAVSL
     EQHKAVHSQE RSFDCKICGK SFKRSSTLST HLLIHSDTRP YPCQYCGKRF HQKSDMKKHT
     FIHTGEKPHK CQVCGKAFSQ SSNLITHSRK HTGFKPFGCD LCGKGFQRKV DLRRHRETQH
     GLK
//
